東陽光藥：中期報告2025.pdf

1、CONTENTS目錄2Financial Highlights財務摘要3Corporate Profile公司簡介7Management Discussion and Analysis管理層討論與分析64Corporate Governance and Other Information企業管治及其他資料80Review Report審閱報告82Consolidated Statement of Profit or Loss and Other Comprehensive Income綜合損益及其他全面收益表84Consolidated Statement of Financial Posit

2、ion綜合財務狀況表86Consolidated Statement of Changes in Equity綜合權益變動表88Consolidated Cash Flow Statement綜合現金流量表90Notes to the Unaudited Interim Financial Reports未經審核中期財務報告附註125Corporate Information公司資料SUNSHINE LAKE PHARMACEUTICAL CO.,LTD./INTERIM REPORT 20252Financial Highlights財務摘要(RMB000)（人民幣千元）Six months

3、 ended 30 June 2025截至二零二五年六月三十日止六個月Six months ended 30 June 2024截至二零二四年六月三十日止六個月Year ended 31 December截至十二月三十一日止年度 202420232022二零二四年二零二三年二零二二年 Revenue營業額1,937,6672,581,9344,018,9056,385,6163,813,566Gross profit毛利1,467,6122,041,8093,058,6315,077,0482,922,189Profit/(loss)from operations經營溢利（虧損）209,895

4、737,544380,5481,766,082(792,939)Profit/(loss)before taxation除稅前溢利（虧損）95,653607,720141,0541,385,462(1,479,823)(Loss)/Profit attributable to equity shareholders of the Company本公司權益股東 應佔（虧損）溢利(46,370)142,143(207,434)184,924(1,209,205)(Loss)/earnings per share每股（虧損）盈利Basic(in RMB)基本（人民幣）(0.11)0.32(0.47)

5、0.44(3.29)Diluted(in RMB)攤薄（人民幣）(0.11)0.32(0.47)0.44(3.29)Total assets總資產12,063,44813,465,17711,931,51412,658,09910,688,983Total liabilities總負債7,459,8638,686,9807,464,0148,482,78011,562,918Net assets/(liabilities)淨資產（負債）4,603,5854,778,1974,467,5004,175,319(873,935)Profitability盈利能力Gross profit margi

6、n毛利率75.74%79.08%76.11%79.51%76.63%Operating profit/(loss)margin經營溢利（虧損）率10.83%28.57%9.47%27.66%-20.79%Net profit/(loss)margin淨利潤（虧損）率0.76%18.34%0.62%15.88%-37.13%3Corporate Profile公司簡介中期報告2025 /廣東東陽光藥業股份有限公司Sunshine Lake Pharma Co.,Ltd.(the“Company”or“Sunshine Pharma”,together with its subsidiaries,